Cardiff Oncology Inc (CRDF)

05:56 AM

New Product Launches: Will They Boost Cardiff Oncology Inc. Stock in 2025Swing Trade Signals - Newser

05:56 AM

Jul 26, 2025

Is Cardiff Oncology Inc. stock a growth or value playWatchlist Winner Update - Metal.it

Jul 26, 2025

Jul 25, 2025

Is Cardiff Oncology Inc. a good long term investmentHigh-octane investment gains - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Published on: 2025-07-25 15:19:32 - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

What analysts say about Cardiff Oncology Inc. stockExplosive capital appreciation - Autocar Professional

Jul 24, 2025

Jul 23, 2025

Cardiff Oncology Inc. Stock Analysis and ForecastExplosive trading opportunities - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What drives Cardiff Oncology Inc. stock priceFast-track wealth growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What makes Cardiff Oncology Inc. stock price move sharplyFree Day Trading Recommendations - Newser

Jul 22, 2025

Jul 18, 2025

Cardiff Oncology: Volatility Afoot With Onvansertib Update Near-Term (NASDAQ:CRDF) - Seeking Alpha

Jul 18, 2025

Jul 15, 2025

How Cardiff Oncology Inc. stock performs during market volatilityControlled Risk High Reward Plan - Newser

Jul 15, 2025

Jul 15, 2025

Why Cardiff Oncology Inc. stock attracts strong analyst attentionAlpha Stock Ideas - Newser

Jul 15, 2025

Jul 11, 2025

Cardiff Oncology (CRDF) Initiated with a Buy at Ladenburg Thalmann & Co. - The Globe and Mail

Jul 11, 2025

Jul 11, 2025

Cardiff Oncology (NASDAQ:CRDF) Earns Buy Rating from Analysts at LADENBURG THALM/SH SH - Defense World

Jul 11, 2025

Jul 11, 2025

Brokerages Set Cardiff Oncology, Inc. (NASDAQ:CRDF) Price Target at $11.70 - Defense World

Jul 11, 2025

Jul 09, 2025

Cardiff Oncology, Inc. (CRDF) Reports 40% Response Rate in mTNBC Trial of Onvansertib + Paclitaxel - MSN

Jul 09, 2025

Jul 08, 2025

Cardiff Oncology stock initiated with Buy rating at Ladenburg Thalmann By Investing.com - Investing.com Canada

Jul 08, 2025

Jul 08, 2025

Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies - GlobeNewswire

Jul 08, 2025

Jul 08, 2025

International Business Times - FinancialContent

Jul 08, 2025

Jul 03, 2025

Cardiff Oncology Up 16%, Insider Buyers Are Up 35% - simplywall.st

Jul 03, 2025

Jul 03, 2025

While institutions invested in Cardiff Oncology, Inc. (NASDAQ:CRDF) benefited from last week's 16% gain, retail investors stood to gain the most - Yahoo Finance

Jul 03, 2025

Jun 27, 2025

Cardiff Oncology: Delayed Trial Data Update Unnerves Investors But Gives Bulls A Final Buy Low Opportunity - Seeking Alpha

Jun 27, 2025

Jun 26, 2025

Cardiff Oncology Holds Annual Stockholders Meeting 2025 - TipRanks

Jun 26, 2025

Jun 24, 2025

Jefferies Initiates Coverage on Cardiff Oncology (CRDF) with Hol - GuruFocus

Jun 24, 2025

Jun 24, 2025

Cardiff Oncology (CRDF) Begins Coverage With Hold Rating from Jefferies | CRDF Stock News - GuruFocus

Jun 24, 2025

Jun 24, 2025

This MakeMyTrip Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday - Benzinga

Jun 24, 2025

Jun 24, 2025

Cardiff Oncology stock initiated at Hold by Jefferies on early data concerns - Investing.com

Jun 24, 2025

Jun 19, 2025

Market Overreaction to Cardiff Oncology's Data Delay Presents a Rare Buying Opportunity - AInvest

Jun 19, 2025

Jun 18, 2025

Cardiff Oncology (CRDF) Stock Reacts to Delayed Clinical Data Up - GuruFocus

Jun 18, 2025

Jun 18, 2025

Cardiff Oncology falls after naming new medical chief ahead of key trial readout - MSN

Jun 18, 2025